UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016985
Receipt number R000019001
Scientific Title Fast Antidepressant Efficacy and Central Mechanisms of Single Low-Dose Ketamine Injection in Treating Major Depression: a double-blind and randomized-controlled trial and image study
Date of disclosure of the study information 2016/06/30
Last modified on 2021/11/18 12:14:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Fast Antidepressant Efficacy and Central Mechanisms of Single Low-Dose Ketamine Injection in
Treating Major Depression: a double-blind and randomized-controlled trial and image study

Acronym

Single Low-Dose Ketamine Injection in
Treating Major Depression

Scientific Title

Fast Antidepressant Efficacy and Central Mechanisms of Single Low-Dose Ketamine Injection in
Treating Major Depression: a double-blind and randomized-controlled trial and image study

Scientific Title:Acronym

Single Low-Dose Ketamine Injection in
Treating Major Depression

Region

Asia(except Japan)


Condition

Condition

Treatment-resistant depression, TRD

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

the project combined with image studies to
study the specific antidepressant mechanisms of ketamine.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

PET
MRI
MADRS

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Ketamine 0.5mg/kg

Interventions/Control_2

Ketamine 0.2mg/kg

Interventions/Control_3

PBO

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

diagnosis of major depressive disorder according to
Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revision
(DSM-IV-TR)

Key exclusion criteria

1) Use of CNS intoxicant within the previous 24 hours or urine toxicology screen positive for drugs of abuse
2) Overdose, within previous 24 hours, of any agent which would compromise
ketamine metabolism
3) Symptoms of substance abuse/dependence(except nicotine dependence) within 6
months
4) Lifetime use of ketamine or phencyclidine(PCP)
5) Diagnosis of psychosis or bipolar disorder

Target sample size

72


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Cheng-Ta Li

Organization

Taipei Veterans General Hospital,Taiwan

Division name

Psychiatry Department

Zip code


Address

No.201, Sec.2, Shih-Pai Rd, Beitou district, Taipei, Taiwan

TEL

+81-1886228757027

Email

on5083@msn.com


Public contact

Name of contact person

1st name
Middle name
Last name Cheng-Ta Li

Organization

Taipei Veterans General Hospital

Division name

Psychiatry

Zip code


Address

No.201, Sec.2, Shih-Pai Road, Beitou district

TEL

+81-1886228757027

Homepage URL


Email

on5083@msn.com


Sponsor or person

Institute

Ministry of Science and Technology

Institute

Department

Personal name



Funding Source

Organization

Ministry of Science and Technology

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Taipei Veterans General Hospital(Taiwan)


Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 12 Month 01 Day

Date of IRB

2012 Year 06 Month 13 Day

Anticipated trial start date

2014 Year 12 Month 31 Day

Last follow-up date

2015 Year 12 Month 31 Day

Date of closure to data entry

2016 Year 03 Month 30 Day

Date trial data considered complete

2016 Year 04 Month 30 Day

Date analysis concluded

2016 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2015 Year 03 Month 31 Day

Last modified on

2021 Year 11 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019001


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name